Home/Filings/4/0001593968-19-000881
4//SEC Filing

Schultz John M 4

Accession 0001593968-19-000881

CIK 0001466026other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 3:00 PM ET

Size

18.1 KB

Accession

0001593968-19-000881

Insider Transaction Report

Form 4
Period: 2019-03-31
Transactions
  • Award

    Common Share Equivalent

    2019-03-31$24.06/sh+147.418$3,54761,318.737 total
    Common Stock (147.418 underlying)
  • Award

    Common Share Equivalent

    2019-03-31$24.06/sh+589.672$14,18861,171.319 total
    Common Stock (589.672 underlying)
  • Award

    Common Share Equivalent

    2019-03-31$24.06/sh+610.349$14,68561,929.086 total
    Common Stock (610.349 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    69,903
  • Common Stock

    (indirect: By Spouse)
    2,750
  • Common Stock

    283,426
  • Common Stock

    (indirect: Agracel, Inc.)
    42,554
Footnotes (7)
  • [F1]Includes holdings through a self-directed IRA or revocable grantor trust
  • [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose
  • [F3]No exercise price for this type of award
  • [F4]Represents common share equivalents acquired by the reporting person under the Issuers Directors Deferred Compensation Plan (DDCP) with respect to director fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees fully vested on the transaction date listed above and become payable upon termination of service as a director.
  • [F5]Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution.
  • [F6]Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates.
  • [F7]Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director.

Issuer

Midland States Bancorp, Inc.

CIK 0001466026

Entity typeother

Related Parties

1
  • filerCIK 0001526231

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 3:00 PM ET
Size
18.1 KB